Literature DB >> 22547679

The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Christine Richter1, Sylvia Messerschmidt, Gerlinde Holeiter, Jessica Tepperink, Sylvia Osswald, Andrea Zappe, Marcus Branschädel, Verena Boschert, Derek A Mann, Peter Scheurich, Anja Krippner-Heidenreich.   

Abstract

The family of tumor necrosis factor receptors (TNFRs) and their ligands form a regulatory signaling network that controls immune responses. Various members of this receptor family respond differently to the soluble and membrane-bound forms of their respective ligands. However, the determining factors and underlying molecular mechanisms of this diversity are not yet understood. Using an established system of chimeric TNFRs and novel ligand variants mimicking the bioactivity of membrane-bound TNF (mTNF), we demonstrate that the membrane-proximal extracellular stalk regions of TNFR1 and TNFR2 are crucial in controlling responsiveness to soluble TNF (sTNF). We show that the stalk region of TNFR2, in contrast to the corresponding part of TNFR1, efficiently inhibits both the receptor's enrichment/clustering in particular cell membrane regions and ligand-independent homotypic receptor preassembly, thereby preventing sTNF-induced, but not mTNF-induced, signaling. Thus, the stalk regions of the two TNFRs not only have implications for additional TNFR family members, but also provide potential targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547679      PMCID: PMC3434479          DOI: 10.1128/MCB.06458-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  80 in total

Review 1.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

2.  TNFR2 - target for therapeutics against neurodegenerative diseases?

Authors:  Ingrid M Nijholt; Ivica Granic; Paul G M Luiten; Ulrich L M Eisel
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

3.  Tumor necrosis factor receptor cross-talk.

Authors:  Petrus J W Naudé; Johan A den Boer; Paul G M Luiten; Ulrich L M Eisel
Journal:  FEBS J       Date:  2011-02-08       Impact factor: 5.542

4.  The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.

Authors:  Wei Tang; Yi Lu; Qing-Yun Tian; Yan Zhang; Feng-Jin Guo; Guang-Yi Liu; Nabeel Muzaffar Syed; Yongjie Lai; Edward Alan Lin; Li Kong; Jeffrey Su; Fangfang Yin; Ai-Hao Ding; Alexandra Zanin-Zhorov; Michael L Dustin; Jian Tao; Joseph Craft; Zhinan Yin; Jian Q Feng; Steven B Abramson; Xiu-Ping Yu; Chuan-ju Liu
Journal:  Science       Date:  2011-03-10       Impact factor: 47.728

Review 5.  Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease.

Authors:  Yoshinori Takei; Ronald Laskey
Journal:  Trends Mol Med       Date:  2008-08-06       Impact factor: 11.951

Review 6.  Using plasma membrane nanoclusters to build better signaling circuits.

Authors:  Angus S Harding; John F Hancock
Journal:  Trends Cell Biol       Date:  2008-07-10       Impact factor: 20.808

7.  Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells.

Authors:  Sharmila Masli; Bruce Turpie
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

8.  A novel juxtamembrane domain in tumor necrosis factor receptor superfamily molecules activates Rac1 and controls neurite growth.

Authors:  Wenjing Ruan; Christopher T Lee; Julie Desbarats
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

9.  Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism.

Authors:  Liqin Ban; Jack Zhang; Limei Wang; Willem Kuhtreiber; Douglas Burger; Denise L Faustman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

10.  Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors.

Authors:  Cornelis J H Pronk; Ole Petter Veiby; David Bryder; Sten Eirik W Jacobsen
Journal:  J Exp Med       Date:  2011-07-18       Impact factor: 14.307

View more
  22 in total

1.  Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes.

Authors:  Simon Neumann; Jan Hasenauer; Nadine Pollak; Peter Scheurich
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

2.  Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages.

Authors:  Francesca M Salmeri; Antonio S Laganà; Vincenza Sofo; Onofrio Triolo; Emanuele Sturlese; Giovanni Retto; Alfonsa Pizzo; Angela D'Ascola; Salvatore Campo
Journal:  Reprod Sci       Date:  2014-05-20       Impact factor: 3.060

Review 3.  Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.

Authors:  Silvia von Karstedt; Antonella Montinaro; Henning Walczak
Journal:  Nat Rev Cancer       Date:  2017-05-24       Impact factor: 60.716

Review 4.  Systemic lupus erythematosus biomarkers: the challenging quest.

Authors:  Cristina Arriens; Jonathan D Wren; Melissa E Munroe; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

5.  Activation of EphA2-EGFR signaling in oral epithelial cells by Candida albicans virulence factors.

Authors:  Marc Swidergall; Norma V Solis; Nicolas Millet; Manning Y Huang; Jianfeng Lin; Quynh T Phan; Michael D Lazarus; Zeping Wang; Michael R Yeaman; Aaron P Mitchell; Scott G Filler
Journal:  PLoS Pathog       Date:  2021-01-20       Impact factor: 6.823

6.  Death Receptor 5 Networks Require Membrane Cholesterol for Proper Structure and Function.

Authors:  Andrew K Lewis; Christopher C Valley; Stephen L Peery; Benjamin Brummel; Anthony R Braun; Christine B Karim; Jonathan N Sachs
Journal:  J Mol Biol       Date:  2016-10-06       Impact factor: 5.469

7.  Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia.

Authors:  Mark B Leick; Harrison Silva; Irene Scarfò; Rebecca Larson; Bryan D Choi; Amanda A Bouffard; Kathleen Gallagher; Andrea Schmidts; Stefanie R Bailey; Michael C Kann; Max Jan; Marc Wehrli; Korneel Grauwet; Nora Horick; Matthew J Frigault; Marcela V Maus
Journal:  Cancer Cell       Date:  2022-04-21       Impact factor: 38.585

Review 8.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

9.  Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2.

Authors:  Anja Krippner-Heidenreich; Catharien M U Hilkens; Nicola J Maney; Gary Reynolds
Journal:  J Immunol       Date:  2014-10-06       Impact factor: 5.422

10.  Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.

Authors:  Yun Jung Oh; Jung Nam An; Clara Tammy Kim; Seung Hee Yang; Hajeong Lee; Dong Ki Kim; Kwon Wook Joo; Jin Ho Paik; Shin-Wook Kang; Jung Tak Park; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.